Yu Wang, Zeng Ruixin, Peng Sun, Hang Yang, Panpan Liu, Man Nie, Yu-Hua Huang, Zhiming Li. "Smart start with tislelizumab as frontline treatment in advanced-stage classical Hodgkin lymphoma：a PET-adapted, chemotherapy-sparing phase 2 study." Blood, 2025. doi:10.1182/blood-2025-3624